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L INTRODUCTION 
The human body is so complex that all those who study.it must utilize models 
to relate and interpret the vast amount of available experimental data. This 
has been true from almost the earliest days of modern physiology and medi­
cine. Until recently these models of whole-body function have been mostly 
qualitative with many being entirely verbal, but with the rise in availability 
of computer systems, more quantitative modeling approaches have begun to 
appear. These quantitative human simulation models have been most success­
ful at the subsystem level where the circulatory system, respiratory system, 
renal system, and thermoregulatory system, among others, have all been 
treated in varying detail. Such a quantitative approach offers several distinct 
advantages over the more traditional, essentially qualitative, modeling struc­
ture. First, alternative hypotheses of function may be subjected to quantitative 
comparison which often suggests the more significant of the hypotheses. 
Second, the interaction between various subsections of a model become more 
apparent in a quantitative formulation. Third, quantitative modeling allows 
one to more readily identify significant unresolved problems relevant to a 
complete understanding of the system under study. When coupled with a 
viable experimental program this produces an iterative protocol, alternately 
using modeling and experiment, to converge toward the truth. Fourth, a 
quantitative approach is a valuable teaching tool, conveying both concepts and 
detailed function of a system. Fifth, the more mathematical type of analysis 
allows a calculation of quantitative values of variables that are difficult or 
impossible to measure. Sixth, a quantitative modeling approach has a pre­
dictive capacity that is important when direct experiments are difficult to per­
form. This predictive ability usually is more significant than the correspond­
ing predictiveness associated with a more qualitative approach. 
For the above reasons a quantitative approach to modeling human physiological 
function with a view towards ultimate application to long duration space flight 
experiments has been undertaken and is now in progress. For the first time, 
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data has been obtained on.the effect of weightlessness on certain aspects of 
human physiological function over relatively extended periods (1-3 months). 
The biomedical investigations of Project Skylab are beginning to reveal an 
interesting pattern of adaptive phenomena occurring in the tightly related 
areas of body fluid volumes, electrolyte and water balance, and circulatory 
function. The experimental situation met in Project Skylab is complex due 
to the difficulty in separating the effects of possible lessened activity 
(deconditioning) from the hypogravic effects. This difficulty is compounded 
by the fact that extrapolation and prediction are most desirable features, 
while at the same time additional, possibly clarifying, experiments are now 
impossible to perform, at least for several years. It is in just such a 
situation that modeling may play an important role. 
This report summarizes tasks accomplished in the modeling area by the 
author during 1973-74. Section II concerns modifications of the long-term 
circulatory model originally developed by Guyton (1, 2). Section III discusses 
design considerations for bilateral interface models whereby dual functioning 
of major subsystem models may obtain. The final section, Section IV, 
addresses itself to the construction of a functioning whole-body model as well 
as the testing of the model versus available data (model verification). 
II. MODIFICATIONS IN THE GUYTON MODEL 
The circulatory model originally developed by Guyton has been modified and 
performance improved in several respects. The main modifications concerned 
the renin-angiotensin system, the baroreceptor system, stress relaxation of 
the vasculature, autoregulation of muscle blood flow, and the red cell system. 
Consideration has also been given to the possible inclusion of gravitational 
effects and incorporation of an acid-base homeostatic system in the present 
model. 
Renin-Angiotensin System 
The original version of the Guyton model did not possess an adequate repre­
sentation of the renin-angiotensin system. In particular, resin secretion
 
per se was not present, and the model did not respond correctly to low-level
 
angiotensin II infusion. The previous model contained what was essentially
 
a black box with angiotensin level dependent on tubular sodium flow. In order
 
to extend the range of applicability of the model a more physiologically
 
oriented section has replaced the previous black box model. A flow chart of
 
the added system is given in Figure 1. The modifications were incorporated
 
in SUBROUTINE HORMON in place of lines 25-34 inclusive. New coding was
 
inserted in this place as follows:
 
25 CALL FUNCTN(PAR, RNS, FUN8)
 
26 RSR=300. *REK*RNS*(1. -ANGS-B*(GFR*CNA-17.75))
 
27 IF(RSIL LT.O. )) RSR=O.0
 
28 RT= RT+ (RSR-CRA*RT)*(I. -EXP(-I/RNK))
 
29 RC = RT/VP
 
30 AN1=CAIV+CAS*RC
 
31 AN2=AN2+(AN1-CAA*AN2)*(1. -EXP(-I/AKA))
 
32 ANC=AN2/VP/ANCN
 
33 ANM=ANMM-AN3 *EXP(-ANC/ANTC)
 
34 IF(ANM. LT.0. 5) ANM=0. 5
 
35 ANSS=A*(ANC-1.)
 
36 ANGS=ANGS+(ANSS-ANGS)*I/ANGT
 
37 ANK=ANM
 
38 IF(ANK. LT. 1. )ANK=4.
 
In addition, line 16 of SUBROUTINE ISC2 was modified to read
 
16 STH=(Z10-POT)*Z11*(1. +ATH*(ANC-1.)).
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Lines 11, 12, 	 and 23 of SUBROUTINE KIDNEY were changed to 
11 AAR=31. 67*VIM*(AUM*ARF+I. -ARF)*GF3*(1. +ANAR*(ANIv-1.))
 
12 RR=AAR+51.66*VIM*(1. +ANER*(ANM-1.))
 
23 TRR=GFR*(O. 8+GP1*(ANK-1. ))/(1. +GPI*(ANK-1. ))+. 025*REK-. 001*REK/AM/AHM"
 
The changes in SUBROUTINE HORMON have the following significance. 
Line 25. 	 Calculation of renin secretion per gram of kidney (RNS) based on 
renal arterial pressure (PAR). (Figure 2) 
Lines 26-27. 	 Calculation of total renin secretion rate (RSR) limited by 0 based on 
renin secretion per gram of kidney (RNS), effective kidney mass 
(300. *REK), angiotensin effect (ANGS), and tubular sodium flow 
(GFR*CNA). 
Line 28. 	 Calculation of total renin amount (RT) by integration of production 
rate (RSR) minus destruction rate (CRA*RT) with integrative damping 
factor RNK. 
Line 29. 	 Calculation of plasma renin concentration (RC) by dividing total 
amount (IRT) by plasma volume (VP). 
Line 30. 	 Calculation of the production rate of angiotensin II (AN1) from the 
infusion rate (CAIV) and the normal production from renin. 
Line 31. 	 Integration of net production rate of angiotensin II to yield angio­
tensin amount (AN2). 
Line 32. 	 Calculation of ratio of plasma angiotensin I concentration to normal 
(ANC) by dividing angiotensin amount by plasma volume (VP) and 
normal angiotensin II plasma concentration (ANCN). 
Lines 33-34. 	 Empirical calculation of the effect of angiotensin II (ANVI) from a 
dose-response curve relating to angiotensin concentration (ANC). 
Line 35. 	 Calculation of steady-state suppressive effect of angiotensin on renin 
production (ANSS). 
Line 36. 	 Calculation of actual suppressive effect of angiotensin II on renin 
(ANGS) by a slow approach to ANSS with time constant ANGT. 
Lines 	37-38. The effect of angiotensin on tubular reabsorption (ANK) is limited 
to values greater than or equal to 1. 
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In SUBROUTINE MISC2, the change allowed thirst and salt intake to depend
 
on angiotensin If levels. In SUBROUTINE KIDNEY, lines 11 and 12 were
 
modified to allow afferent and efferent arteriolar resistances to depend on
 
angiotensin I1 effect (ANM) with sensitivities ANAR and ANER, respectively.
 
Line 23 was modified to increase tubular reabsorption of water (THR) with
 
high angiotensin levels.
 
Baroreceptor System
 
The baroreceptor system of the original Guyton model has been upgraded by
 
direct inclusion of separate aortic and carotid effects and by separate inclus­
ion of the autonomic influence on contractility of the heart and whole-body
 
unstressed volume. Appropriate delays and resetting have been utilized. A
 
flow chart for the modified system is given in Figure 3. The modifications
 
were made in the program in the following areas. In SUBROUTINE AUTO
 
lines 17-20 inclusive were replaced by
 
17 CALL FUNCTN(PA1, AUCB, FUN9)
 
18 CALL FUNCTN(PA1, AUAB, FUN10)
 
19 AiB = 1. +CCB*AUCB+CAB*AUAB
 
20 CONTINUE.
 
Line 36 was replaced by
 
36 CALL FUNCTN(PAI ,AUHI, FUNIl)
 
36A AUH2=AUHI-AUH3
 
36B AUH=AUH+(AUH2-AUH)*I2*6. /Z8
 
36C IF(STA. GT.. 00001)AUH=STA
 
and line 38 was replaced by
 
38 CALL FUNCTN(PA1, VOTI, FUN12)
 
38A VOT2 = VOT1 - VOT3
 
S8B VOT= VOT+(VOT2-VOT)*I2*6. /Z8
 
38C IF(STA. GT.. 00001)VOT = 4.25.
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In SUBROUTINE VISCI the following lines were inserted after line 27. 
27A AUH3 = AUH3+(AUH2-1. )*I*AUK 
27B VOT3 = VOT3+(VOT2-4.25)*I*AUK. 
The significance 	of these changes are as follows. For SUBROUTINE AUTO 
Lines 17-20. 	 Calculation of the contribution of the baroreceptors to auto­
nomic stimulation (A1B) based on graphical interpolation. 
Both aortic (AUAB) and carotid (AUCB) are included with 
relative sensitivities CAB and CCB. (Figures 4 and 5) 
Lines 36-36C. 	 Calculation of the autonomic effect on cardiac contractility 
(AUH) by graphical interpolation (Figure 6) with a delay and 
resetting mechanism. 
Lines 38-38C. 	 Calculation of the total unstressed volume of the systemic 
circulation based on graphical interpolation (Figure 7) with 
a delay and resetting mechanism. 
For SUBROUTINE MISC1 
Lines 27A-27B. 	 Resetting mechanism for heart contractility (AUH3) and 
unstressed volume (VOT3). 
Vascular Stress 	Relaxation 
Stress relaxation of the vascular system has been extended by the inclusion 
of new components with different time constants for action. These new com­
ponents are associated with six-hour and fourteen-day relaxation phenomena. 
Changes were made in SUBROUTINE iVISC1 where the following insertions 
were made after 	line 11. 
11A V61=V61+(SR1*(VVE-. 301)-V61-V71)/Z 
11B V71=V71+V61*(1. -EXP(-I/SRL)) 
11C V62=SR2*(VVE-. 301)-V72 
lD V72=V72+V62 *I/SRVM 
lE VVT=X6*VV7+X7V71+X8*V72. 
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The significance of these changes are as follows: 
Line 11A. 	 Calculation of the rate of progression of intermediate-term 
vascular stress relaxation (V61) by subtracting the refer­
ence venous volume (. 301) from the excess venous volume 
(VVE). SRI is the intensity of such stress relaxation. 
Line 11B. 	 Calculates the stress-relaxation volume due to intermediate­
term stress relaxation (V71) by integration of the rate of 
progression (V61) with time constant SRL. 
Lines 11C- Similar to the previous two lines except that the long-term 
lD effect (V72) is calculated. 
Line lE. 	 Calculation of total stress-relaxation volume (VVT) by taking 
a weighted sum of the three previously calculated effects. 
Other Changes 
Other changes were made in the basic model and these are included here for 
completeness. 
In SUBROUTINE HEMO these changes are as follows. Line 21 was replaced 
by 
21 VASO = 0.116*VOT 
21A VAE = VAS-VASO. 
Line 26 was replaced by 
26 VRAO = 0. 0235*VOT 
26A VRE = VRA-VRAO. 
Line 29 was replaced by 
29 VPAO = 0. 072*VOT 
29A VPE VPA-VPAO. 
Line 36 was replaced by 
36 VLAO = 0.0941*VOT 
36A VLE = VLA-VLAO. 
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Lines 44-46 were replaced by 
44 IF(ANU. LT.. 6)ANU=. 6 
45 VVE=VVS-0. 694*VOT-(ANU-1.)*ANY 
45A VVSO=. 694*VOT+VVT+(ANU-1. )*ANY 
46 VV8=VVS-VVSO. 
In SUBROUTINE MUSCLE line 24 was replaced by the following:
 
24 AMS = AMS+(POE-AMS)*(i. -EXP(-I/A4K))
 
25 POF = 1.+POU*PDO
 
26 AM2 = AM2+(POF-AM2)*I/A5K
 
27 AMM = AM2*AMS.
 
In SUBROUTINE CAPMBD line 26 was replaced by 
26 VPD = VPD+(TVD-VTC+VTL-VUD-DFP-VPD+RTR-VIL)/Z1 
27 VP = VP+VPD*I/Z3. 
In SUBROUTINE IONS the following line was inserted after line 9. 
9A IF(KO. GT.. 00001)KOD=KO. 
In SUBROUTINE KIDNEY lines 23-24 were replaced by 
23 IF(DESC. GT. 0.0) GO TO 151 
24 VUGF=0.2*GFR 
24A GO TO 152 
24B 151 VUGF=VUGF+(0. 2*GFR-VUGF)*I/UOC 
24C 152 VUD=VUGF/(1. +GP1*(ANK-1. ))-0. 025*REK+0. 001*REK/AM/AHM 
After line 25 the following line was inserted. 
25A IF(VOB. GT.. 00001) VUD =VOB. 
After line 31 the following line was inserted. 
31A 'IF(NAO. GT.. 00001)NOD=NAO. 
32 
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Line 32 was changed to read 
NED-IfIlD*STH-NOD+RNA. 
In SUBROUTINE MISCI the following line was added after line 19. 
19A IF(VINT. GT.. 00001)TVD=VINT. 
The significance of these changes are as follows: The changes in SUBROUTINE 
HEMO allow a direct calculation of the unstressed volume of each vascular 
compartment (VASO, VRAO, VPAO, VLAO, VVSO) based on the total unstressed 
volume (VOT), angiotensin (ANU), and stress relaxation (WVT). In SUBROUTINE 
MUSCLE the change allowed an intermediate-term autoregulation term (AM2) to 
have an effect. In SUBROUTINE CAPMBD the change allowed the direct inclus­
ion of a water infusion term (RTR) and an insensible loss term (VIL). In SUB-
ROUTINE IONS the change allowed control of potassium excretion rate through 
KO. The changes in SUBROUTINE KIDNEY allowed a time delay in urinary 
output (through changes in DESC) and allowed control of urinary output through 
VOB and sodium excretion through NAO as well as controlled sodium infusion 
through RNA. The change in SUBROUTINE MISC1 allowed for control of drink­
ing through VINT. 
All new terms introduced into the model are defined in Appendix A. Normal 
steady-state values of these variables are given there as well. 
Further Studies 
Although the preceding changes were the only ones implemented, other systems 
were studied for possible inclusion in the Guyton model. These systems include 
a new acid-base homeostatic system, a modified red-cell model, and a mecb­
anism with potential utility for the inclusion of gravitational effects. 
Appendix B of this report contains a study report on acid-base homeostasis. 
This was prepared as a preliminary to actual insertion of some elements of 
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acid-base control in the Guyton model. Although there are many reasons why 
such an insertion would be desirable, it is recommended that the acid-base 
system not be added to the Guyton model at the present time. This recom­
mendation is made because (1) such an addition is non-trivial and experi­
ments should be conducted to obtain the proper quantitative information, 
(2) no direct experiments related to acid-base phenomena are part of Project 
Skylab, and (3) some elements of acid-base effects are already Implicitly 
contained in certain control elements, particularly as regards autonomic 
stimulation. These latter implicit effects would have to be removed if an 
explicit formulation were to be inserted. 
The red cell model presently utilized as a subsystem of the Guyton model 
is physiologically inaccurate in response tostimuli for production. The 
present model is based on non-muscle tissue P02 with a fall in P02 initiating 
increased production. Although the idea of using such a change in oxygen 
partial pressure to increase production is probably sound, the receptor site. 
is probably located in the kidney, not the other non-muscle areas. Also the 
response in the present model leads to anemia whenever P02 changes- due to 
a hypervolumic state are compensated for by flow increases. A replacement 
subsystem was investigated for red cell control which was based on a receptor 
site location in a constant flow, constant metabolizing area of the body, 
presumably a portion of the kidney. This new model is somewhat better than 
the former one, but improvements are intended shortly which will make the 
system even more realistic. At the time these improvements are made, 
the new section will be inserted in the original Guyton model. 
Since th6 effect of gravity upon return from space on the cardiovascular 
system is of some interest, it might prove fruitful to incorporate gravita­
tional effects into the Guyton model. At first glance, this might seem 
impossible since the Guyton model contains only five systemic volume com­
partments with no distinction made as to physical location. Buy by using 
a three compartment model (upper body, trunk, lower body) the effect of 
gravitational changes on appropriate variables may be simulated. These 
effects include an average decrease in venous pressure at the right heart 
due to standing, a hydrostatic pressure effect at the kidney, the gravitational 
effect on capillary pressure, the gravitational effect on pressure at the baro­
receptor site, the effect of the muscle pump, and the effect of abdominal 
compressiun. 
Model Experiments 
A series of experiments were run using the most recent version of the model 
in an attempt to demonstrate validity of the changes made. These experiments 
include low level angiotensin infusion, double Goldblatt clamp, and salt-induced 
renoprival hypertension on both normal and baroreceptor denervated subjects. 
Tables 1 - 4 contain the results of some of these experiments. In each case 
the variables tabulated are extracellular fluid volume in liters (VEC), auto­
nomic effect, ratio to normal (AU), cardiac output in liters/min (QLO), mean 
arterial pressure in mm Hg (PA), urinary output in ml/min (VUD), and 
angiotensin I1 concentration, ratio to normal (ANC). These results compare 
quite favorably with recent experiments (3). In each case the results repre­
sent an improvement over previous simulations using the former model 
version. Certain other simulations in the particular area of infusions of 
various types were also made (4, 5). 
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In. DESIGN CONSIDERATIONS FOR BILATERAL INTERFACE MODELS 
Most physiological modeling has been concerned with function at the sub­
system level, or with whole-body function of limited extent. In an effort to 
realistically extend modeling capabilities beyond this, an attempt has been 
made to design separate bilateral interface models each composed of a long­
term circulatory model (Guyton) and one other of the three major models 
under study (thermoregulatory (6), respiratory (7), short-term circulatory 
(8)). 
These design considerations will be discussed for each model in turn. The 
design will be purely qualitative with actual implementation introducing quan­
titation. Only the respiratory-circulatory combination included implementa­
tion. 
Respiratory-Circulatory Interface 
Let us assume that one has two different models of physiological function, 
each of which is designed specifically to simulate detailed function of different 
aspects of function. In general, each model will have overlap areas with the 
other, as well as non-overlapping areas. Each model may respond to the same 
as well as different stimulii. If the models are compatible in time as regards 
duration of feasible simulations, it may be quite possible to form a composite 
or bilateral model which offers advantage to each subsystem in effecting sim­
ulation. 
To combine compatible models requires that all overlap areas be eliminated, 
that the effect of stimulii acting on one model be properly related to the 
other, and no non-overlapping areas act to yield contradictory results. 
In the case of the respiratory and circulatory models, compatibility exists 
over the short term only (10-30 minutes). This limitation exists because of 
inherent weaknesses in the respiratory model. It is obvious that there must 
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be areas of overlap of these two models. In the respiratory model blood 
must flow to provide tissue oxygen and to remove excess carbon dioxide. 
In the circulatory model breathing of some sort must be present to oxygenate 
the available hemoglobin. In each case though, for these models, the elements 
of overlap consist of a fairly detailed version in one model and a relatively 
crude version of the same function in the other model. - This made elimination 
of overlap fairly easy. It was decided to allow the circulatory model to 
determine all flows (except brain blood flow), all metabolic parameters (except 
brain oxygen consumption), and all factors related to total hemoglobin present. 
The respiratory system would determine the fractional saturation of hemoglobin 
in aortic blood, which the circulatory system uses, as well as all the other 
respiratory parameters not directly involved with the circulatory system. 
The implementation of this scheme is presented in detail elsewhere (9, 10, 11), 
and will not be covered again here. Briefly, it was found that the models 
performed adequately during exercise, but not during other non-steady state 
perturbations. This might have been expected had the interfacial structure 
been subjected to a more critical examination. In particular, during exercise 
each model was capable of running independently of the other and crudely sim­
ulated the correct performance of the other model. So, it would be expected 
that the models would simulate exercise well when acting together. With the 
other forcings, like CO 2 inhalation, only one of the independent models was 
designed to handle the stimulation. New terms should have been added to the 
other model to represent the effect of this new driving force (e. g., CO2 
exerts a local dilatory and central constrictory effect). Since this was not 
done, it might be expected that the overall system would respond improperly. 
Consideration of design questions for this bilateral model has been very use­
ful in emphasizing that at least three questions must be faced in combining 
even compatible models.- The -easiest problem to solve generally relates to 
elimination of overlap areas. The effect of neglect of stimulti on one model 
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acting directly on the other was well illustrated with CO 2 forcing. The 
ability of non-overlapping areas acting to yield poor results is illustrated 
by a bilateral heart failure experiment where the combined respiratory­
circulatory model was only utilized after independent circulatory stability 
was obtained. The results are again poor, but this time because the circu­
latory model had abnormal fluid volumes and, undoubtedly should have had 
abnormal bicarbonate concentrations in the blood and tissues. 
Long Term-Short Term Circulatory Interface 
Although the long term circulatory model (Guyton) is well-suited to the sim­
ulation of certain experimental situations relevant to the Skylab mission, some 
pertinent experiments are difficult to simulate effectively with only a five 
compartment systemic circulatory loop. In particular, one of the main Skylab 
experiments pertaining to the circulatory system, the lower body negative 
pressure (LBNP) experiment, presents some difficulty due to the lack of a 
sufficient number of compartments. A nodel that performs adequately to sim­
ulate LBNP has been developed (8), but this model contains 28 systemic cir­
culatory compartments. This-latter model also has various serious weaknesses 
of its own, the most important of which concern the lack of fluid and protein 
transfer into and out of the systemic compartment and the lack of a drinking 
mechanism or functioning kidney. Thus, whenever fluid regulation is.impor­
tant, errors are likely. Because of these things, this large systemic model 
is limited in application to short term experiments. 
One solution to problems of the above type is to utilize the long term model to 
compite fluid volume shifts and then to automatically define initial operating 
conditions for the short term model. The sjhort term model would then be 
stimulated with local exercise, positional differentiation in a gravitational 
field, or LBNP. The problems involved in.,accomplishing this type of bilateral 
interface are related tb the obvious non-uniqueness of the transition between 
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the models, and the fact that the controlling system for the short term model 
should be initialized also. Thus, if A-V muscle blood flow is set by a small 
model having only one muscle bed, how would the flow be distributed in a larger 
model with muscle beds contained in the arms, legs, and trunk? It turns out 
that such degrees of freedom must be chosen to correspond to known physio­
logical conditions in the subject at the time the model-model interaction takes 
place. If there is a sparsity of known conditions, intuition must be used as a 
guide, just as in initial model development. It should be possible to combine 
computer experiments with known physiological experimental results and 
define the initialization procedure. 
Automatic initialization of a compartmentalized model of systemic circulation 
should at the very least consist of volume initializations. Circulatory function 
without inclusion of adaptive phenomena is known to be highly sensitive to 
volume changes. Other important candidates for inclusion in initialization 
procedures pertain to flow or resistance changes, and to the state of the con­
trolling system. The design of such an initialization scheme is complicated 
by the fact that each of these areas is affected by the other two. Thus, if 
volume increases, flow also increases, and the controller state changes. The 
problem lies in separating the effects sufficiently that a plan can be formulated 
to obtain a proper initialization. It is doubtful whether a single adjustment 
(like a volume change) can give the necessary model correspondence). 
It is suggested that actual design of this interfacial system would best be done 
through implementation of a routine capable of transferring information be­
tween the two models and then to use a system of essentially trial and error 
to complete the linkage. The procedure might be as follows. Step 1: initialize 
total blood volume and unstressed volume. Step 2: change the autonomic effect 
to initialize heart rate. Step 3: change resistances.to initialize flows. 
Step 4: repeat steps 2 and 3 until proper equilibrated values are obtained for 
volumes, flows, and pressures. 
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Thermoregulatory-Circulatory Interface 
The thermoregulatory-circulatory interfacial design has much in common 
with the re.spiratory-circulatory interface discussed earlier in that a division 
of tador, of sorts, along physiological lines is possible. Thus, all blood 
flows should be extracted from the circulatory system, all heat flows should 
be compied from the thermoregulatory system. But in the complex response 
that pertains to thermal driving forces on both local and central controlling 
systems for blood flow, this division of labor is not so apparent. What is 
clear is that a certain amount of additional modeling on the subsystem level 
itself is necessary to be able to properly relate thermal stresses to the 
circulatory system. This is because of the fact that the two models were 
developed on quite different bases as regards the treatment of circulation. 
This makes it much more difficult to find analogous qualities of circulatory 
control in the models, and to correspondingly exchange information. Thus, 
design considerations must await further in-depth review of thermoregulatory 
function in terms of common cardiovascular function. 
IV. DESIGN OF A WHOLE-BODY MODEL 
A whole-body model is assumed to be a large-scale dynamic mathematical 
model of the human body capable of responding to both long and short term 
stresses of various kinds. These stresses may act on any one or any collect­
ion of the "subsystems" of which the model is composed. It is assumed that 
the stresses are well-defined in the sense that the model will be specifically 
designed to cope with each applied stress. 
It is impossible to face the modeling problems that one must solve to con­
struct this whole-body model without actually implementing the model. 
Design and implementation are so intertwined in a model of this size that it 
is actually wasteful of resources to try to develop specific detailed approaches 
until implementation. Instead, more is to be gained prior to actual implemen­
tation by considering alternative general approaches. 
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There are probably two main approaches to modeling a large system com­
posed of (at least) two subsystems. First, each subsystem could be modeled 
independently, possibly by different people using different hypotheses. After 
each subsystem worked properly in some test situation(s), the subsystem 
models could be combined into a unit by restructuring or redesigning the 
subsystems to work together. Second, the system as a whole could be 
attacked and a cohesive model assembled utilizing a single non- contradictory 
set of hypotheses, and designed to function as a unit from the beginning. 
Although these two approaches might seem very different, if each is pursued 
properly, with the same goals in mind, the final results should be quite 
similar. In particular, it is probably not less work to follow the first path 
mentioned above since considerable effort could be spent in redesign consid­
erations when subsystem models are combined. It would seem to be prefer­
able only to study the components of a large system by subsystem analysis, 
but to model the whole system as a unit utilizing only the basic ideas on sub­
system function, not subsystem structure per se. This is the recommenda­
tion made for the development of a whole-body model. By utilizing ideas 
and experience gained from a separate study of major body subsystems, it 
should be possible to construct a completely unified model which incorporates 
major system function in a cohesive way. It should be no more difficult to do 
this than to combine several models together in workable fashion for non­
trivial simulation stress. 
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TABLE 1. 
CONTINUOUS ANGIOTENSIN INFUSION 
(Normal subject; Rate: 350 ng/min) 
Time After 
Infusion 
0. 
8 hr. 
1 day 
3 days 
7 days 
VEC 
15.05 
15.46 
15.68 
15.19 
15.30 
AU 
1.0 
.84 
.80 
:90 
.98 
QLO 
5.12 
4.99 
5.27 
5.09 
5.10 
PA 
102 
116 
126 
134 
140 
VUD 
1. 
.2 
1.5 
.9 
.9 
ANC 
1.0 
5.0 
4.3 
4.6 
4.6 
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TABLE 2.
 
CONTINUOUS ANGIOTENSIN INFUSION 
(Baroreceptor Denervated Subject; Rate: 350 ng/min) 
Time After VEC QLO PA VUD ANC 
Infusion 
0 15.05 5.15 102 .0 1.0
 
8 hr. 15.42 5.09 142 0.6 5.0
 
I day 15.35 5.14 143 1.0 4.7
 
3 days 15.31 5.09 142 0.9 4.6
 
7 days 15.33 5.08 142 0.9 4.6 
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TABLE 3. 
GOLDBIATT HYPERTEN4SION 
(Normal Subject; Renal Pressure Decrease: 50 mm Hg) 
Time After 
Clamp 
0 
8 hr. 
1 day 
3 days 
7 days 
VEC 
15.06 
15.88 
15.84 
15.45 
15.46 
AU 
1.0 
.72 
.57 
.91 
1.0 
QLO 
5.09 
4.95 
5.60 
5.-51 
5.52 
PA 
101 
126 
139 
149 
149 
VUD 
1.0 
0.2 
1.1 
0.5 
0.5 
ANC 
1.0 
22. 
2.7 
2.0 
1.8 
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TABLE 4 
GOLDBLATT HYPERTENSION 
(Baroreceptor Denervated Subject; Renal Pressure Decrease: 50 mm Hg) 
Time After VEC QLO PA VUD ANC 
Clamp 
0 15.05 5.16 102 1.0 1.0 
8 hr. 15.55 5.02 156 0.2 7.5 
1 day 15.78 5.65 149 0.7 1.7 
3 days 15.50 5.56 149 0.5 1.7 
7 days 15.46 5.58 150- 0.5 1.7 
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FIGURE 2. 	 RELATION BETWEEN RENAL ARTERIAL PRESSURE (PAR) 
AND RENIN SECRETION RATE PER GRAM OF KIDNEY(RNS). 
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FIGURE 5. RELATION BETWEEN EFFECTIVE ARTERIAL PRESSURE AT 
BARORECEPTORS (PAl) AND AORTIC BARORECEPTOR 
EFFECT (AUAB). (FUN 10) 
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CARDIAC CONTRACTILITY (AUHi). (FUN 11) 
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APPENDIX A 
GLOSSARY OF TERMS 
The following is a list of all variables recently added to the long-term model 
together with normal values for these variables. Independent variables are 
indicated by * 
A* - sensitivity of suppressive effect of angiotensin on renin secretion (0. 15) 
AKA* - damping factor involved in angiotensin production (10. 0) 
AMS - short-term muscle autoregulatory effect (1. 0). (This was formerly 
called AMM.) 
AM2 - intermediate-term muscle autoregulatory effect (1.0) 
ANAR* - sensitivity of angiotensin effect on afferent arteriolar resistance in the 
kidney (0. 1) 
ANCN* - normal angiotensin concentration in plasma (25.9 ng/l) 
ANER* - sensitivity of angiotensin effect on efferent arteriolar resistance in the 
kidney (0. 1) 
ANGS - fractional suppression of renin secretion influenced by angiotensin 
concentration (0.) 
ANGT* - time constant for attainment of angiotensin suppression of-renin 
(360. min) 
ANK - angiotensin effect on tubular reabsorption (1. 0) 
ANMM* - maximum effect of angiotensin (2.5) 
ANSS - steady-state fractional renin suppression caused by angiotensin (0.) 
ANTC* - exponential parameter used to obtain angiotensin dose-response curve 
(3.94) 
AN2 - angiotensin 11 amount (82. 5 ng) 
AN3 - parameter used to obtain angiotensin dose-response curve (1. 93) 
ATH* - sensitivity of angiotensin effect on thirst and salt intake (0. 058) 
AUAB - autonomic response of aortic baroreceptors (0.) 
AUCB - autonomic response of carotid baroreceptors (0.) 
AUvH1 - initial response of pressure effect on contractility (1. 0) 
AUtt2 - adapted response of contractility due to pressure (1. 0) 
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APPENDIX A (Cont'd) 
GLOSSARY OF TERMS 
AUH3 - extent of adaptation of contractility response due to pressure (1. 0) 
A5K* - time constant for intermediate-term muscle autoregulation (1000. min) 
B* - sensitivity of suppressive effect of renal tubular sodium flow on renin 
secretion (0. 15) 
CAA* - time constant for angiotensin destruction (1. 0 min) 
CAB* - sensitivity of total baroreceptor effect on aortic baroreceptors (3. 0) 
CAIV* - angiotensin infusion rate (0. 0) 
CAS* - rate constant for angiotensin production from renin (0. 0825) 
CCB* - sensitivity of total baroreceptor effect on carotid baroreceptors (3. 0) 
CRA* - time constant for renin destruction (0. 0655) 
DESC* - delay in renal response used during salt loading (0.) 
GPI* - sensitivity of angiotensin effect on renal tubular reabsorption (0. 215) 
KO* - controlled value for potassium excretion (0.) 
NAO* - controlled value for sodium excretion (0.) 
POF - sensitivity control for intermediate-term muscle autoregulatory loop 
(1.0) 
POU* - sensitivity of intermediate-term muscle autoregulation (0. 05) 
RC plasma renin concentration (1000-. ng/1) 
RNA* - controlled intake rate of sodium (0.) 
RNK* - damping factor involved in renin production (30. 0) 
RNS - rate of renin secretion per gram of kidney (0. 71 ng/min) 
RSR - total rate of renin secretion for 300 grams of kidney (213 ng/min) 
RT - total renin amount in plasma (3179 ng) 
RTR* - controlled infusion rate of water (0.) 
SRL* - time constant for intermediate vascular stress relaxation (360. min) 
SRM* - time constant for long-term vascular stress relaxation (20160. min) 
SR1* - intensity factor for intermediate vascular stress relaxation (0. 25) 
SR2* intensity factor for long-term vascular stress relaxation (0. 25) 
UOC* - delay time constant for kidney during salt loading (960.) 
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APPENDIX A (Cont'd) 
GLOSSARY OF TERMS 
VASO - unstressed volume of arterial compartment (0. 495 1)
 
VIL* - controlled insensible water loss rate (0.)
 
VINT* - controlled intake rate for water (0.)
 
VLAO - unstressed volume of pulmonary venous and left atrial compartment
 
(0.4 1) 
VOB* - controlled urinary output rate (0.) 
VOT - total body systemic unstressed volume (4.25) 
VOTI - initial arterial pressure effect on whole-body unstressed volume 
(4.25) 
VOT2 - adapted arterial pressure effect on whole-body unstressed volume 
(4.25) 
VOT3 - extent of adaptation of arterial pressure effect on whole-body unstressed 
volume (0.) 
VPAO - unstressed volume of pulmonary arterial compartment (0. 306 1) 
VRAO - unstressed volume of right atrial compartment (0. 1 1) 
VUGF - urinary flow due to filtration (. 025) 
VVSO - unstressed volume of venous compartment (2.96 1) 
V61 - rate of change of intermediate stress-relaxation effect (0.) 
V62 - rate of change of long-term stress-relaxation effect (0.) 
V71 - increased vascular volume caused by intermediate stress relaxation 
(0.) 
V72 - increased vascular volume caused by long-term stress relaxation (0.) 
X6* - weighting factor for short-term vascular stress relaxation (0. 8) 
X7* - weighting factor for intermediate-term vascular stress relaxation (0. 4) 
X8* - weighting factor for long-term vascular stress relaxation (1. 0) 
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I. 	Introduction
 
Homeostasis, which has been termed "the central theorem of the
 
physiology of the intact higher animal organism" (1), is manifest con­
tinually in the human through the response of the total collection of 
subsystems of the body to normal and abnormal challenges. One of the 
most vigorously defended parts of the human system concerns acid-base 
balance and pH regulation, presumably because of the importance of such
 
regulation to the myriad of biochemical reactions occurring in the cells
 
(2). Indeed, death follows with certainty, if pH regulation is not main­
tained at near normal capacity.
 
Acid-base regulation is a cooperative phenomena in vivo with body
 
fluids, extracellular and intracellular buffers, lungs, and kidneys all
 
playing important roles. The present account is much too brief to be con­
sidered a review of present knowledge of these regulatory systems, and should
 
be viewed, instead, as a guide to the elements necessary to construct a
 
simple model of the mutual interactions of the acid-base regulatory sys­
tems of the body. More detailed information is available elsewhere (1,
 
3-8).
 
II. 	Cells
 
Whole-body intracellular space is an extremely inhomogenous fraction
 
of the body with wide diversity in both function and form. In an ideal
 
sense only, which may be useful as a first approximation, however, cell space
 
may be characterized by average results weighted in some appropriate manner.
 
Thus, metabolic reactions in the cells produce large quantities of
 
carbon dioxide and smaller quantities of other acid end products. It is
 
estimated that normal metabolic formation of carbon dioxide is approximately 
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200 ml/min (STPD) or 8.98 mmol/min (1 mmol CO = 22.26 ml CO), while22 
production of other acids amounts to only 50-100 mtol/day, or 0.035 - 0.07 
mmol/min (9). The cells contain chemical buffer systems capable of serving 
as intermediate storage reservoirs of these acid end products, but in a nor­
mal balance situation the acid produced is transmitted to the interstitial 
fluid and thus to the blood to be excreted by the lungs and kidneys. 
The main chemical buffers of the cells are proteins, organic phosphates, 
bicarbonate, and bone carbonate. Bone is generally differentiated from other
 
intercellular forms and considered by itself. The contribution of bone to
 
acid-base homeostasis is potentially large but generally not well understood
 
except in extreme cases (10). Bone will be treated only cursorily in most 
of what follows. Concentrations appropriate to tissue intracellular space 
(not bone) appear to be (11) 
bicarbonate: 10 mmol/L, 
phosphates: 100 mmol/L, 
proteins: 60 mmol/L.
 
In view of the fact that intracellular volume is approximately 25 L, the
 
stores of cellular buffer anions are large.
 
The red blood cells, (erythrocytes) have their own distinct function
 
to perform in acid-base control and they will be considered in more detail in
 
the section on blood. Their volume is approximately 2 L, although the water
 
content of red cells is only 1.3 L, if a protein content of 35% is assumed.
 
During acute and chronic attacks of both respiratory and metabolic
 
(non-carbon dioxide) components of acid-base balance, there is no doubt about 
the participation of the cell in homeostatic response (12-16), but the nature 
of the response in some cases is mechanistically unclear (17). This point 
will be discussed later in relation to a simple model. 
Under the normal conditions, the average pH of the cell seems to be 
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about 7.0 (18). The cell membrane is generally assumed to be highly
 
permeable to carbon dioxide gas with the Pco2=45-50 mm Eg at equilibrium.
 
The permeability of the membrane to bicarbonate or hydrogen ions is gener­
ll
a y regarded as being somewhat less (6, 19, 20).
 
III. Interstitial Fluid
 
The interstitial fluid which lies between the cells consists of a small
 
amount of free fluid (0.5 L) and a large portion held in a gel (11.5 L).
 
For most purposes connected with acid base balance, the interstitial fluid
 
behaves as if the water were all free. Almost all dissolved substances,
 
with the exception of protein, move freely between the plasma and the inter­
stitial fluid through the capillary pores and perfect mixing can generally be
 
assumed for most substances. In this way, the cells are able to communicate
 
almost directly with other parts of the body through theblood. In a similar
 
way, the plasma has a large reservoir of materials at its disposal to assist
 
in "buffering" changes which occur locally. Thus, with the exception of
 
protein, the constituents of interstitial fluid should be very similar to
 
plasma. This is indeed found to be the case, but the concentration of various
 
ions are unequal in interstitial space and plasma due to the Donnan or Gibbs-

Donnan effect. It is easy to show that in the presence of a non-diffusable
 
charged ion on one side of a membrane, all other diffusible charged ions
 
(not pumped or otherwise effected) must distribute themselves unequally on
 
the two sides of the membrane (21).
 
The only buffer of any real significance in interstitial space is bi­
carbonate whose concentration in interstitial water is determined from the
 
corresponding concentration in plasma water by the relation
 
[HCO3 ] SF = r [HCO 1 p (1) 
where [-..] denotes concentration in mmol/L H20 and r is the experimentally 
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determined Donnan factor, generally assumed to be 1.05 for anions
 
(21). Note that the concentrations here are relative to liters (n.kilo­
grams) water, not plasma volume. Thus, due to the presence of 7% pro­
tein in plasma VP, H20 = 0.93 Vp. For interstitial fluid (2% protein)
 
the correction is usually negligible.
 
A second buffer system exists in interstitial fluid, the phosphate 
system (M2P4' HPO4). The total buffering power of this system is usually 
negligible in comparison with the bicarbonate system in vivo and will 
generally be neglected in what follows. Less than 1% of the buffering is 
accomplished by the phosphate system in most circumstances. 
IV. Blood
 
Blood consists of two parts, an extracellular fluid of about 3 L volume
 
and 7% protein, and a cellular part of about 2 L volume and 35% protein. The
 
red cell membrane is permeable to all normal ionic species except protein.
 
The major constituents of plasma relative to acid-base functions in 
vivo are bicarbonate and protein. Both of these substances act-as buffers 
for hydrogen ion changes, with the bicarbonate being the more important.
 
Plasma concentrations of bicarbonate and the various protein forms differ in
 
the various parts of the systemic circulation due to local changes in relative
 
portions of oxygen, carbon dioxide, and hydrogen ion carried in the blood.
 
In normal arterial plasma, pH = 7.4, [CO2] = 1.2 mmol/L-, and [HCO] = 
24 mmol/L, on the average. In venous plasma, typical figures might be 
pR = 7.37, [CO2] = 1.35 ol/L, and [HCO ] = 25.1 mmol/L 
Erythrocytes, on the other hand, contain hemoglobin in addition to
 
bicarbonate, and it is hemoglobin which plays the principal role in carbon
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dioxide, as well as oxygen, transport. On the average, 34 g. of hemoglobin
 
is contained in 100 ml. of red cells and with a normal hematocrit of about 
40, blood usually contains about 15 g. of hemoglobin per 100 ml. These
 
values may have considerable local variation. The protein hemoglobin in
 
vivo has a net negative charge. It is capable of combining with, and thereby
 
transporting, both oxygen and carbon dioxide, and at the same time is capable
 
of buffering hydrogen ions. The molecular weight of hemoglobin is approxi­
mately 68,000 g. and one mole of hemoglobin is capable of combining with
 
four moles of oxygen. It is usual to measure hemoglobin amounts either in
 
grams or in milliequivalents on an oxygen basis. Thus, 1 mole of hemoglobin
 
contains 4 equivalents of hemoglobin (or 1 milliequivalent weight(meq) of 
hemoglobin = 16.7 g.). Hemoglobin combined with oxygen to its fullest extent 
is called oxyhemoglobin and will be denoted 'HbT02" while hemoglobin c:arrying 
no oxygen is called reduced hemoglobin and will be denoted "Fb". The negative 
charge will be suppressed. Each gram of hemoglobin is capable of carrying 
approximately 0.06 mmol of oxygen (or 1.34 ml STP) at full saturation. The 
fraction saturation of hemoglobin is the fraction of hemoglobin in the blood 
that is in the form H1O2 . This fraction varies from 0.97 for arterial blood 
down to about 0.70 for venous blood (under normal resting conditions). The 
relation between the saturation level (usually expressed as per cent satura­
tion) and the oxygen partial pressure is expressed by the oxygen dissociation
 
curve of hemoglobin (22). 
In general, a buffered solution is one which tends to maintain a constant 
pR in the face of challenge by acid additions or withdrawals. Such a solution 
contains appreciable concentrations of various weak acids and their coorespon­
ding highly ionized "salts". For example, consider a solution containing 0.1 
mole/L sodium acetate and 0.05 mole/L acetic acid (at 25 0C). 
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The pH is approximately
 
pH = 4.57 + log [0-oll 4.87.
 
Addition of 0.01 mole of hydrochloric acid to a liter of this solution would
 
lead to an approximate new pH given by
 
4.709
 p = 4.57 + log [ 
= 4.75.
o.06 

Addition of this same quantity of acid to a liter of pure water (pH = 7.)
 
leads to a new pit of 2. The resistance of the buffer solution to pH changes
 
is clear.
 
As stated above hemoglobin serves as a buffer (not the only one) in 
blood. In fact both oxyhemoglobin and reduced hemoglobin have buffering 
abilities. The presence of oxygen makes the oxyhemoglobin a stronger acid 
than reduced hemoglobin and consequently the reduced hemoglobin is a better 
buffer than oxyhemoglobin. The body uses this fact to good advantage since
 
oxygen is given up and acidic waste picked up in the tissue. The buffering
 
ability of a solution is generally expressed by means of its titration curve
 
which is the relation between the amount of acid added to the solution and
 
the pH of the solution. The experimentally important variable is the slope
 
of the titration curve and the term "buffer value" is usually defined as the
 
negative of the slope of the titration curve (5). The units of buffer value
 
are usually mmol/liter/pH unit and this unit is termed a slyke (sl) (5).
 
The buffer value of a solution containing more than one buffer substance
 
is the sum of the buffer value of each substance. The buffer value of each
 
substance is directly proportional to the concentration of that substance.
 
Transportation of carbon dioxide from the tissues to the lungs is
 
effected by both the plasma and the red cells. In general, carbon dioxide
 
diffuses through the interstitial space into the plasma and red cells. A
 
small amount of carbon dioxide gas dissolves in the plasma and an even smaller
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amount forms a direct carbamino compound with plasma proteins. Some of the 
dissolved CO2 reacts with water to form carbonic acid which ionizes slightly
 
co2 + H20 -4H 2 CO3 V H + HCO (2) 
The carbon dioxide diffusing into the erythrocytes remains partially dissolved 
but the largest portion of that which enters either combines directly with 
hemoglobin to form carbamino - CO2 or hydrolyzes under carbonic anhydrase 
catalysis to form carbonic acid which ionizes to a great extent. This 
+
ionization takes place because the e ions produced are buffered by the
 
hemoglobin, and then the HC03 ions largely diffuse back into the plasma. 
The carbonic anhydrase present allows the hydrolysis reaction to proceed
 
sufficiently rapidly that equilibrium is attained almost instantaneously.
 
Thus, the major forms of carbon dioxide in the plasma are dissolved carbon
 
dioxide and bicarbonate, and in the red cell are dissolved carbon dioxide,
 
carbamino - C02., and bicarbonate. Typical average values for carbon dioxide
 
distribution in one liter of normal arterial blood would be
 
plasma: H03 = 14.40 mmol
 
C02 (dissolved) = 0.72 mmol
 
Red Cell: HCO = 4.83 mmol 
CO2 (dissolved) = 0.40 mmol
 
Carbamino-CO2 = 1.00 mmol 
In normal venous blood corresponding values would be 
Plasma: HC03 = 15.06 mmol 
CO2 (dissolved) = 0.81 mmol 
.Red Cell: HC03 = 5.33 mmol 
CO2 (dissolved) = 0.45 mmol 
Carbamino - CO2 = 1.50 mmol 
Thus plasma bicarbonate is the major carbon dioxide carrier, but the distri­
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bution depends greatly on the presence of the red cell with its carbonic
 
anhydrase and hemoglobin.
 
V. 	Respiratory System
 
The major acid end product of metabolism, carbon dioxide, is produced
 
by the body at the rate of about 200 ml/min at rest. Each day a minimum 
of about 300 liters of carbon dioxide is generated and in a steady state
 
precisely this amount must be disposed of. It is one of the major functions
 
of the respiratory system to effect this disposal. By the respiratory sys­
tem 	is meant the lungs together with their controlling center in the brain and
 
nervous system. Normally, except during exercise, arterial PC02 is the
 
main stimulus to control of alveolar ventilation. This stimulus appears to 
be due to neural impulses transmitted from two distinct sets of receptors: 
central receptors located in the brain-cerebrospinal fluid region, and in peri­
pheral receptors located mainly in the carotid and aortic bodies (23, 24). 
The exact cause of the stimulus is difficult to determine, but either PCO2 
itself or hydrogen ion level (in a non-hypoxic state) would suffice with hy­
drogen ion level more likely centrally. The peripheral receptors seem to 
account for somewhat less of the respiratory response than the central receptors. 
Basically, if arterial PCO2 rises, arterial hydrogen ion levels increase 
slightly which stimulates the peripheral receptors to increase firing and 
stimulate respiration to some extent. The major response, in this case, 
is due to the response of the central receptors. An increase in arterial 
PCOcauses a PC0 shift in the interstitial fluid of the brain due to the 
02 %i 
lipid solubility of carbon dioxide. Cerebrospinal and interstitial fluid 
are not as well buffered as the blood and a barrier to rapid exchange of 
buffers (mainly bicarbonate) between these systems prevents ion equilibration 
from occurring rapidly. Thus the PCO2 increase in the central area causes 
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a much larger hydrogen ion change there and a correspondingly larger increased
 
stimulation to ventilation. This stimulation disappears with time as bi­
carbonate adjustments are made which allow the pH to return to normal and 
the main stimulus reverts to the peripheral receptors. The increased venti­
lation tends to reduce the arterial P completing the feedback loop. 
When hydrogen ion concentration rises peripherally due to addition of non­
volatile acid, alveolar ventilation is stimulated because of the increased 
activity of the peripheral receptors. The fall in carbon dioxide levels is 
transmitted centrally and causes a competitive depression of the ventilation. 
As time passes, central adjustments in bicarbonate levels are made which allow
 
alveolar ventilation to increase. This increase in ventilation tends to drive
 
arterial pH back to normal.
 
VI. Renal System
 
Addition of acidic substances other than carbon dioxide or of sub­
stances with basic properties to the blood causes deviations in hydrogen
 
ion, bicarbonate and carbon dioxide levels from normal and compensation for
 
these deviations cannot be completely made by the buffering systems of the
 
body discussed up to now (the respiratory system may be considered a phys­
iological buffer). It is the role of the renal system to effect complete
 
compensation. The active, constant role the kidney plays even in normal
 
states is, in fact, large and important. With a normal glomerular filtra­
tion rate of 125 ml/min and a plasma bicarbonate level of 24 mol/l, 3
 
millimoles of bicarbonate are filtered each minute. If this were not almost
 
completely reabsorbed, the body would rapidly be depleted of one of its most
 
important chemical buffers. In fact, bicarbonate seems to be completely
 
reabsorbed, in effect, by the body in the normal state.
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Renal reabsorption of bicarbonate is accomplished as a result of
 
the interaction between hydrogen ion actively secreted by the tubules and
 
filtered bicarbonate with consequent diffusion of the resulting carbon
 
dioxide back into the cells where hydration leads to bicarbonate reforma­
tion. The source of the original hydrogen ions secreted is not clear,
 
but it is clear that the process is extremely carbon dioxide sensitive.
 
On a phenomenological level, the renal clearance (excretion rate/plasma
 
concentration) of bicarbonate appears to exhibit a threshold occurring at
 
a plasma concentration of approximately 24 - 28 mmol/l. The maximal tubular
 
reabsorptive capacity per unit volume of glomerular filtrate thus deter­
mined is about 2.4 - 2.8 meq/100 ml of glomerular filtrate with arterial 
PCO2 = 40 mm Hg and increases with increasing arterial PCO2 . This appar­
ent threshold now seems to be an artifact of the experimental technique 
used in its measurement and the current view is that a complex interaction 
between extracellular volume, potassium, and adrenal steroids control bi­
carbonate reabsorption (25).
 
The kidney's fundamental method of reaction to increased acid loads
 
in the body must be such as to not only reabsorb filtered bicarbonate but 
also to generate new bicarbonate at an enhanced level. During an acid
 
load plasma-bicarbonate level falls and hence filtered bicarbonate decreases. 
Acid secretion (hydrogen ion) by the tubules continues at a relatively en­
hanced level determined by blood PCO2 For each hydrogen ion secreted a
 
bicarbonate ion is generated in peritubular blood. The secreted hydrogen
 
ions are transported to the urine by formation of ammonium ions and by com­
bination with phosphate buffers. Thus the acidosis is corrected. The proces
 
continues until the normal state is attained (ifpossible), but total com­
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pensation takes from one to several days. With an increasing base load,
 
plasma bicarbonate rises increasing filtered bicarbonate. Once acid secre­
tion is exceeded, progressive amounts of bicarbonate are lost directly in
 
the urine and correction follows.
 
VII. Acid-Base Abnormalities
 
Modern clinical terminology for disturbances in acid-base regulation
 
is as follows (5). Acidosis refers to an abnormal physiological process
 
characterized by gain of acid or loss of base by the extracellular fluid
 
of the body. Alkalosis is an abnormal physiological process characterized
 
by gain of base or loss of acid by the extracellular fluid of the body. The
 
prefix metabolic (metabolic acidosis, metabolic alkalosis) is used to denote
 
abnormal processes characterized by primary gains or losses of strong acid,
 
strong base, or bicarbonate from the extracellular fluid. The prefix
 
respiratory (respiratory acidosis, respiratory alkalosis) refers to abnormal
 
processes in which there are primary changes in the rate of alveolar venti­
lation relative to the rate of carbon dioxide production.
 
Abnormalities in blood acid-base parameters, which are taken to be
 
pH, bicarbonate concentration, and PCO2 of plasma, are characterized by
 
the following terms. Acidemia means pH is lower than normal. Alkalemia
 
means pH is higher than normal. Hypobasemia means bicarbonate concentra­
tion is lower than normal while hyperbasemia means bicarbonate concentration
 
is higher than normal. Hypocapnia and hypercapnia refer to a decreased or
 
increased level of PCO2 relative to normal.
 
The abnormal physiological processes, acidosis and alkalosis, may
 
lead to a variety of different abnormalities in the blood acid-base para­
meters due to the secondary or compensatory reactions of the body to the
 
primary disturbance.
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A gain of strong acid or a loss of strong base or bicarbonate from
 
the extracellular fluid all lead to a fall in the concentration of bicar­
bonate in the extracellular fluid. This fall is the prime abnormalitity of
 
metabolic acidosis. In acid loading the bicarbonate level falls because
 
of the buffering of the acid by the bicarbonate. The body responds to this 
loss of bicarbonate in several ways. The cell fluids effectively transfer
 
bicarbonate into the extracellular space either directly by bicarbonate
 
movement or indirectly by hydrogen ion uptake or by both processes. The
 
respiratory system responds by adjusting PCO to a lower value. The renal
 
2
 
system responds by effectively generating new bicarbonate through acid se­
cretion.
 
In metabolic alkalosis the primary disturbance is due to a gain of
 
bicarbonate or loss of acid (gain of base) by the extracellular fluid.
 
Since the loss of acid is buffered by the bicarbonate system, in either
 
case a gain of bicarbonate occurs. Cells respond by transferring hydrogen
 
ions into extracellular fluid thus eliminating some bicarbonate. The res­
piratory system increases PCO. The renal system rather rapidly raises
 
excretion of bicarbonate.
 
In respiratory acidosis, alveolar ventilation is decreased relative
 
to the rate of carbon dioxide production. Carbon dioxide levels in the
 
body increase leading to a fall in pH. The buffer systems respond to the
 
decreased pH and bicarbonate levels increase. The kidney increases its ex­
cretion of titratible acid and ammonia and thus raises bicarbonate levels
 
even further. These responses tend to raise pH.
 
With respiratory alkalosis, alveolar ventilation rises relative to car­
bon dioxide production leading to a primary loss of carbon dioxide. This
 
causes pH to rise. The buffer system acts to retard the rise by reducing
 
45
 
bicarbonate levels in the body and the renal system by excreting bicarbonate
 
in the urine. In this way pH tends to fall.
 
VIII. A Simple Model
 
In this section a quantitative approach to acid-base homeostasis is
 
presented which incorporates much of the data and experimental findings out­
lined in the preceding sections. This approach will utilize a modeling
 
format as it is intended to include the resultant model as a subsystem
 
model in a more complete analysis of overall circulatory regulation. In
 
fact, the current intention is to use a presently available circulatory
 
model (26) as the main component of a much larger model with systems such
 
as the acid-base homeostatic system discussed here being added at a later
 
date. With this in mind, many circulatory variables may be assumed known
 
as the large model will provide values for these. Such variables include
 
cardiac output, hematocrit, oxygen consumption, cell volume, etc. A second
 
point worthy of mention in this connection is the fact that the overall
 
model is basically designed-for the study of intermediate to long term
 
effects and that the present model must be adequate for the representation
 
of experiments of days to-weeks duration. Previous models which have con­
sidered acid-base response have not been adequate for simulation of even
 
a one day response.
 
The present model consists of a compartmental approach with seven dis­
tinct compartments. These are chosen as lungs, brain, cerebrospinal fluid,
 
tissue (non-brain) intracellular space, tissue (non-brain) extracellular
 
space, arterial blood and mixed venous blood. The kidneys are represented
 
explicitly only in their effect on bicarbonate reabsorption and new bi­
carbonate production. The assumption is made that the carbon dioxide buffer
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curve (or equivalently the carbon dioxide dissociation curve) represents
 
the steady-state situation and serves also as an adequate predictor of
 
the steady state during transient events. Hypoxia will not be of interest
 
here and the dynamics of the oxygen system will be kept very simple, just
 
as they,are in the large circulatory model.
 
To begin with, consider the situation in the tissue (non-brain) in­
tracellular space (IC). Let BIC represent the bicarbonate concentration 
of this compartment in mmol/l, Pic the partial pressure of C02 in mm Hg, 
MC the total metabolic production of CO2 in all forms in mol/min,MIc 2MHIC
 
the effective net metabolic rate of formation of hydrogen ion in mmol/min,
 
WIC the total concentration of C02 , BSIc the concentration of bicarbonate 
at pH = pHSIC Corresponding definitions hold for tissue (non-brain)
 
extracellular space and the subscript EC is used to denote these. Then.
 
the conservation equations become
 
d[VIC WIC] = MCIc + kl(PEC - PIC + k2 (BEC - BI) - MHIC, (3) 
dt 
and 
d[V 
dt.C 
BSI 
IC 
= k(B
2 ECHIC 
- MI
IC 
(4) 
These equations are to be used in conjunction with the CO2 buffer or dissocia­
tion equation for the compartment which is
 
= BSI - 0 tpHIC- pisIci + ACPIC (5) 
where
 
1c=vPK1 +ilo [IC ­-pH -- 'IC).
PHIC= C , og - AIC PIC . ' (6)p 
The first term on the right side of Equation (3) represents metabolic produc­
tion of CO2, the second term represents diffusion of C02 from extracellular 
space, the third term represents "net effective bicarbonate flux" from extra­
cellular space, and the last term represents "net metabolic hydrogen ion pro­
duction". The effect of these last two terms is to raise or lower the bi­
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carbonate concentration at fixed pH and Equation (4) represents this fact.
 
In Equation (5) the total carbon dioxide concentration is obtained by
 
summing the bicarbonate concentration and the non-bicarbonate CO2 concen­
tration. Bound CO2 amounts (carbamino compounds) are assumed negligible
 
here. The slope of the CO2 titration curve is given by IC and is assumed
 
constant for this compartment. Note that
 
BI= BS1C - SIC {HC- pHS10} -(7) 
Typical values for the constants appear to be k = 3.0, k2 = 0.0027,
 
pRSIc = 7.0, AC = 0.03, pKIc = 6.1, and aIC = 15. These values were chosen 
so that when MCIc 9.0, MRIc= 0.04, PEC = 45, and BEC = 25.87 a steady 
state obtains with BIC = 11.3, PI = 48., and pHi0 = 7.0. For the tissue 
(non-brain) extracellular space (EC), the conservation equations become
 
d-VEC WEe] = QEC(WAB - WVB) - kI(PEc - ) 2 BC + ' (8) 
dt CEC i B 
and
 
d [Ve BSEC] = R - k2 (E - B) (9) 
and the corresponding CO2 buffer or dissoiation equation including the
 
Haldane effect is
 4 
WEC = BSEC - 8EC (PHC - pHSECI + k3 Hb(!-Sv) + ABC PEC (10) 
with -
WEC - At";PEC 
AECBEP 
In these equations QEC represents the blood f w to the tissues (non-brain),
 
PH represents the net renal generation of,bicarbonate, H5 represents the
 
hemoglobin concentration in gram % (g/100 ml blood), SVB represents the
 
fractional oxygen saturation of the hemoglobin, WAB represents the total
 
CO2 content of arterial blood, and WVB represents the total CO2 content of
 
venous blood draining the tissues. It is assumed that the venous blood and
 
extracellular space are in equilibrium " - an effects are ignored. Then
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WVB = WEC and PVB = PEC" The slope of the titration curve, 0EC is, 

determined from the plasma and interstitial fluid protein levels and the
 
amount of hemoglobin present in the blood. The relation is
 
V P v IP I 1.51 VB b (12)
 
EC V C + -

EC C EC 
where PRp is the plasma protein concentration, PKI is the interstitial 
fluid protein concentration, and Hb is the hemoglobin concentration in
 
blood, all expressed in g% (grams/100 ml), and VP is the plasma volume, 
VB the total blood volume, and VI is the interstitial volume. Typical 
values for the new parameters are k = 0.09, pHSEc = 7.38, AC = 0.03, 
SVB = 0.7, pKC = 6.1, PRp = 7.0, PR = 1.27, Hb = 15.0 and BSEC = 25.5. 
with these values a steady state obtains with PEC = 45., BEC = 25.87, 
RB = 0.04 when QEC = 4.25, and WAB = 25.1. 
For the brain (B) compartment no subdivision into extracellular and
 
intracellular space is assumed. Instead, a cerebrospinal fluid (CSF)
 
compartment is introduced which is able to rapidly exchange CO2 with the
 
brain by diffusion. A slow exchange (or pumping) of bicarbonate appears 
possible with the ultimate goal of CSF pH regulation. Thus, no (or only
 
slight) bicarbonate flow seems to occur due to bicarbonate imbalance. 
Rather, the mechanism is an active extrusion or uptake to return pH to, 
normal after CO2 diffusion. For the brain, the appropriate balance equa­
tion is 
P )
d [VW] =MC B + QB(WAB - W + k4 (Pcs + BT (13)
 
where MC5 represents total metabolic CO2 production of the brain, and ET
 
represents effective bicarbonate transfer into the brain from the CSF com­
partment. The CO2 buffer curve is 
WB =-BSB - Btp - PSB +APB (14) 
where the terms have their usual meaning. It is assumed that brain venous 
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blood (BVB) has the same PCO2 as brain tissue itself, but a buffer curve is. 
given by 
WBVB SBB - PHSBBI + k5HblSB'VBB) (15)- {P'B + ABVBP.-
The cerebrospinal fluid (CSF) compartment is taken to contain a solution 
of bicarbonate in water that rapidly exchanges CO2 with thebrain by 
diffusion, and slowly "pumps" bicarbonate to maintain steady state pH. 
Thus 
d[VCSF ACsF PCSF = k4 (PB - PCSF) (16) 
at 
and 
d[V BS F = - BT. (17)
dEt CSF CS? 
The PHcs F is then determined from 
PHosr = P1 CSF + log [B CSF ] (18) 
CSF CSF 
It is assumed that BT is such that PHCSF returns to normal, pHSCSF) with 
time constant TCSF* Thus, BCSF approaches a steady state value BSSCSF given 
by 
(Pc - PK0sF)F
 
BSScs F = A CSFCSF (19) 
In this case
 
BT= (BSScsF - BCF)/TCsF. (20) 
Typical parameter values for the above equations are MCB = 2.25, QB = 0.75, 
WAB = 25.1, WBVB = 28.1, k4 = 0.000365, PCSF = 47.8, PB = 47.8, BT = 0, 
ESB = 27.3, B = 28.9, pH3 = 7.38, pHSB = 7.38, A = 0.03, BSEv B = 25.1, 
PBVB = 7.37, pHSBv B = 7.37, k5 = 0.3, Hb = 15, SBVB = 0.66, 
VCS F = 0.1, VB = 1.0, ACSF = 0.03, TCS F = 1000., and PK CSF = 6.08. 
The buffer power of blood is given by 
%VB = -+ 1.51 Hb (21) 
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where Rb is the hemoglobin concentration in g/100 ml blood, and PR is the
 
plasma 	protein concentration in g/100 ml plasma. The quantity BSBVB also
 
changes as "effective bicarbonate" is exchanged with cell space through the
 
equation
 
- k2 (BEC - BIC)
 
d BSvB = (22)
t 	 VEC
 
Note that VEC is assumed constant, an assumption which introduces no sig­
nificant error.
 
The mixed venous blood entering the lung consists of a weighted average
 
of venous blood from the brain and from the tissue areas. If Q is the total
 
cardiac output
 
W V = 	 EC WEC + QB WBVB" (23) 
Q 
Normally WMV = 4.25 x 27.2 + 0.75 x 28.1 = 27.3 meq/i. 
5. 5.
 
In the lung reservoir the mass balance equation for CO is
2 
d [VIFA = AP FAI + 0.0269 QI WV - WA)X. 	 (24) 
This equation is derived by neglecting the difference between inspired and 
expired ventilation. FA is the volumetric fraction of CO2 in dry alveolar 
gas, FI is the corresponding volumetric fraction in dry inspired gas, VA is 
alveolar ventilation in 1/min (BTPS), VL is the effective alveolar volume, 
and the 0.0269 is a conversion factor which changes meq/min total CO2 flow 
to 1/min flow at BTPS. In fact 
- 22.26 m x 1 1 x 760 x 310 = 0.0269 
meq 1000 ml 713 273 
since STPD means P = 760 mm Hg, T - 2730K and BTPS means P = 760 - 47 = 713 
mm Hg, T = 273 + 37 = 3100K at sea level. The relation between volumetric 
fraction and partial pressure is 
PA = 713 FA 	 (25)
 
at sea 	level. It is assumed that arterial PCO2 equals alveolar PCO2 , PA*
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Then at equilibrium VA = 5.27 1/min, F A = 0.056 or PA = 40. Knowledge of 
PA allows computation of WAB through the buffer or dissociation equation 
WA = BSAB -B CpH. - pHSAB + k5 Hb(I-SAB) + AABP A . (26)B 
7
Here 8A = BVB (Equation (21) ), BSAB = 23.9, pHSAB = .4 , k5 = O., 
SAB 0.99, and AAB = 0.03. BSAB changes with the same rate as BSEC and 
BSvB ' therefore 
d BS - k2(BEC - BI).
 (27)
 
dt VEC 
Alveolar ventilation itself must be determined from a controller equation like 
VA= 0' 11 AB + C2PCSF + C3 - (28)
 
Renal function enters this model only through the net renal generation
 
of extracellular bicarbonate R. This includes net reabsorption and net
 
generation through titratable acid and ammonia secretion. The amount of
 
bicarbonate filtered at the kidney is given by
 
AMT. FILTERED = GFR (WAB - AABPA) (29)
 
where GFR is the total glomerular filtration rate. Normally GFR = 0.125
 
l/min so that the amount filtered is approximately 3 meq/min. If
 
WAB - AABPA (=BAB) is less than T meq/1,all bicarbonate is reabsorbed (at,
 
PA = 40 mm Hg, TM= 24). The value of TMdepends on arterial PCO2 and it
 
is assumed that
 
TM = 13.12 + 0.272 PA' PA<40 
= 16.72 + 0.182 PA' PA Ao (30)
 
Thus if PA risesTM rises and bicarbonate level-rises buffering pH changes.
 
The bicarbonate lost by not being reabsorbed is
 
BAL = GFR{WAB - AABPA - TM (31) 
if WAB - AABPA > TM and is 0 otherwise. 
Normal titrable acid secretion amounts to about 0.013 meq/min while nor­
mal ammonia secretion is 0.027 meq/min. The assumption is made that titra­
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table acid excretion is 0.13 meq/min if WAB - AABPA < 18 and that TA = 0 
if WAB - AABPA > 24.5. In between
 
TA = 0.486 - O.OI98(WAB - AABPA). (32) 
The response is assumed instantaneous. Ammonia excretion is assumed to have 
a steady state maximum of 0.3 meq/min if W - APA < 18, but there is a 
delay associated with attainment of that maximum with time constant TNH
 
If WAB - AABPA > 24.5 ammonia excretion is assumed zero. The maximum ammonia 
excretion then takes the form 
NH 3M = 1.126 - 0.046(WAB - AABPA) (33) 
otherwise. Actual ammonia excretion is simulated by the equation 
d NH3 = (NHM - NH3)/TNH (34)dt 
if NH3M > NH If N13 > NH3M then NH3 = NH3M. This allows a rapid fall 
in ammonia production.
 
The basic model is complete. Much is left out and much remains to be
 
discussed in detail. The influence of pH on other body functions has not
 
been mentioned at all. It is this effect on the body that is the prime moti­
vation for studying the systems that regulate pH. Ventilation control was
 
only briefly mentioned. The effect of aldosterone, potassium, and chloride
 
levels was not considered. Such a treatment would be unpardonable were it
 
not meant to be a simple first effort. What remains is actual computer
 
simulation coupled with a delineation of the effects of acid base imbalance
 
on the major controller functions of the body.
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